实用肝脏病杂志 ›› 2025, Vol. 28 ›› Issue (2): 190-193.doi: 10.3969/j.issn.1672-5069.2025.02.008

• 病毒性肝炎 • 上一篇    下一篇

超声瞬时弹性成像诊断慢性乙型肝炎合并脂肪肝患者肝纤维化效能研究*

余锴, 梅云华, 周金容, 程正银   

  1. 430040 武汉市 武汉科技大学附属第十二临床医院/武汉市东西湖区人民医院超声影像科(余锴);感染病科(梅云华);呼吸内科(周金容);放射影像科(程正银)
  • 收稿日期:2024-11-25 出版日期:2025-03-10 发布日期:2025-03-11
  • 通讯作者: 周金容,E-mail:491698434@qq.com
  • 作者简介:余锴,男,40岁,大学本科,主治医师。E-mail:yuki840000@163.com
  • 基金资助:
    *湖北省武汉市医学科研项目(编号:WX20B18)

Ultrasonic transient elastography in predicting liver fibrosis in patients with chronic hepatitis B and liver steatosis

Yu Kai, Mei Yunhua, Zhou Jinrong, et al   

  1. Cheng Zhengyin. Department of Ultrasound, District People's Hospital,12th Clinical Hospital Affiliated to Wuhan University of Science and Technology,Dongxihu,Wuhan 430040, Hubei Province,China
  • Received:2024-11-25 Online:2025-03-10 Published:2025-03-11

摘要: 目的 探讨应用超声瞬时弹性成像(TE)技术诊断慢性乙型肝炎(CHB)合并脂肪肝患者肝纤维化的效能。方法 2023年1月~2024年6月我院诊治的100例CHB合并肝脂肪变患者,均接受MRI测量的肝脏质子密度脂肪分数(PDFF)评估肝脂肪变,使用TE检查行受控衰减参数(CAP)和肝脏硬度检测(LSM)。采用多因素Logistic回归分析CHB患者发生中重度肝脂肪变的影响因素。结果 在100例CHB合并肝脂肪变患者中,经MRI-PDFF检查发现,轻度肝脂肪变49例(49.0%),中度肝脂肪变28例(28.0%)和重度肝脂肪变23例(23.0%);重度组BMI、甘油三酯、低密度脂蛋白、LSM和CAP水平分别为(28.8±2.2)kg/m2、(3.6±0.3)mmol/L、(3.9±0.5)mmol/L、(10.5±2.0)kPa和(317.5±20.0)dB/m,均显著高于中度组【分别为(26.5±2.1)kg/m2、(2.5±0.3)mmol/L、(3.3±0.4)mmol/L、(7.2±1.4)kPa和(280.5±11.4)dB/m,P<0.05】或轻度组【分别为(23.2±2.1)kg/m2、(1.8±0.3)mmol/L、(2.9±0.3)mmol/L、(6.4±0.8)kPa和(257.4±4.1)dB/m,P<0.05】;多因素Logistic回归分析显示,BMI(OR=2.818)、低密度脂蛋白(OR=2.179)和CAP(OR=1.852)是CHB患者发生中重度肝脂肪变的独立影响因素(P<0.05);重度、中度和轻度肝脂肪变组显著性肝纤维化发生率分别为69.6%、35.7%和10.2%,三组差异显著(P<0.05)。结论 使用TE测量CAP和LSM诊断CHB合并肝脂肪变患者肝纤维化临床应用价值较高,适合初步判断病情进展。

关键词: 慢性乙型肝炎, 肝脂肪变, 肝纤维化, 超声瞬时弹性成像, 诊断

Abstract: Objective The aim of this study was to investigate ultrasonic transient elastography (TE) in predicting liver fibrosis (LF) in patients with chronic hepatitis B (CHB) and concomitant liversteatosis(LS). Methods 100 patients with CHB and LS were encountered in our hospital between January 2023 and June 2024, and all underwent MRI for proton density fat fraction (MRI-PDFF) and TE scan for controlled attenuation parameter (CAP) and liver stiffness measurement (LSM). Multivariate Logistic regression analysis was applied to evaluate risk factors for LS occurrence. Results Of the 100 patients with CHB and LS, MRI-PDFF found mild LS in 49 cases (49.0%), moderate LS in 28 cases (28.0%) and severe LS in 23 cases (23.0%); body mass index (BMI), serum triglyceride, low density lipoprotein cholesterol (LDL-C), LSMand CAP in CHB patients with severe LS were (28.8±2.2)kg/m2, (3.6±0.3)mmol/L, (3.9±0.5)mmol/L, (10.5±2.0)kPa and (317.5±20.0)dB/m, all significantly higher than [(26.5±2.1)kg/m2, (2.5±0.3)mmol/L, (3.3±0.4)mmol/L, (7.2±1.4)kPa and (280.5±11.4)dB/m, respectively, P<0.05] in those with moderate LS or [(23.2±2.1)kg/m2, (1.8±0.3)mmol/L,(2.9±0.3)mmol/L, (6.4±0.8)kPa and (257.4±4.1)dB/m, respectively, P<0.05] in those with mild LS; multivariate Logistic regression analysis showed that BMI(OR=2.818), LDL-C(OR=2.179)and CAP(OR=1.852)were all risk factors for occurrence of LS in patients with CHB(P<0.05);incidences of significant LF in CHB patients with severe, moderate and mild LS were 69.6%, 35.7% and 10.2%, significantly different among them (P<0.05). Conclusion Application ofTE is efficacious in predicting LF in patients with CHB and LS, which might help preliminarily screening in clinical practice.

Key words: Hepatitis B, Liversteatosis, Liver fibrosis, Ultrasonic transient elastography, Diagnosis